ArticleNeuro-oncology advances

Chimeric antigen receptor (CAR)-T-cell therapy for glioblastoma: what can we learn from the early clinical trials? A systematic review.

Justine Tin Nok Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.